3-153163195-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002886.4(RAP2B):c.502G>T(p.Ala168Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,597,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002886.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAP2B | NM_002886.4 | c.502G>T | p.Ala168Ser | missense_variant | 1/1 | ENST00000323534.5 | NP_002877.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAP2B | ENST00000323534.5 | c.502G>T | p.Ala168Ser | missense_variant | 1/1 | NM_002886.4 | ENSP00000319096 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000187 AC: 4AN: 213436Hom.: 0 AF XY: 0.00000857 AC XY: 1AN XY: 116748
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1445740Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 2AN XY: 718222
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.502G>T (p.A168S) alteration is located in exon 1 (coding exon 1) of the RAP2B gene. This alteration results from a G to T substitution at nucleotide position 502, causing the alanine (A) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at